Uzma Sarwar
About
Uzma Sarwar is a scholar working on Epidemiology, Infectious Diseases and Immunology.
According to data from OpenAlex, Uzma Sarwar has authored 28 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 8 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Uzma Sarwar's work include Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Immunotherapy and Immune Responses (3 papers). Uzma Sarwar is often cited by papers focused on Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers) and Immunotherapy and Immune Responses (3 papers). Uzma Sarwar collaborates with scholars based in United States, United Kingdom and Pakistan. Uzma Sarwar's co-authors include Julie E. Ledgerwood, Richard A. Koup, Barney S. Graham, Galina V. Yamshchikov, Søren P. Sheikh, Sandra Sitar, Steen Gammeltoft, Robert T. Bailer, Gitte Lund Christensen and Jesper V. Olsen and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.
In The Last Decade
Uzma Sarwar
26 papers receiving 703 citations
Peers
Uzma Sarwar
Claudia R. Libertin United States
Michael T. Melia United States
Francisco Moreno Spain
Joshua A. Lieberman United States
Craig S. Boutlis Australia
Robert Luo United States
Isabelle Ravaux France
Alice Pong United States
Xiaohui Wang China
Bruno Granwehr United States
Citations per year, relative to Uzma Sarwar Uzma Sarwar (= 1×)
peers
Claudia R. Libertin
Countries citing papers authored by Uzma Sarwar
Since
Specialization
Citations
This map shows the geographic impact of Uzma Sarwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uzma Sarwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uzma Sarwar more than expected).
Fields of papers citing papers by Uzma Sarwar
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Uzma Sarwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uzma Sarwar. The network helps show where Uzma Sarwar may publish in the future.
Co-authorship network of co-authors of Uzma Sarwar
This figure shows the co-authorship network connecting the top 25 collaborators of Uzma Sarwar. A scholar is included among the top collaborators of Uzma Sarwar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uzma Sarwar. Uzma Sarwar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Madhi, Shabir A., Beate Kampmann, Eric A. F. Simões, et al.. (2025). Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine. Obstetrics and Gynecology. 145(2). 147–156.
2.
Davis, Mark M., William Towner, Elliot DeHaan, et al.. (2025). P-596. Immunobridging Demonstrating Effectiveness of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Adults 18-59 Years of Age at High Risk of Severe RSV Disease in a Phase 3 Trial: The C3671023 MONeT Study Results. Open Forum Infectious Diseases. 12(Supplement_1).
3.
Sarwar, Uzma, et al.. (2024). Association of Low Serum Ferritin Levels in Patients Having Alopecia Areata: A Case Control Study. SHILAP Revista de lepidopterología. 38(2). 90–94.
4.
Sarwar, Uzma, et al.. (2021). SOCIAL SUPPORT, QUALITY OF LIFE AND MENTAL HEALTH PROBLEMS AMONG FEMALES WITH AND WITHOUT MENSTRUATION PROBLEMS: A COMPARATIVE STUDY. SHILAP Revista de lepidopterología. 14(4). 206–210.
5.
Sarwar, Uzma, et al.. (2020). Cutaneous impact of surgical mask versus N 95 mask during covid-19 pandemic: Incidence of dermatological side effects and response of topical methylprednisolone aceponate (MPA) treatment to associated contact dermatitis. Journal of Pakistan Association of Dermatology. 30(4). 650–655.
6.
Carter, Cristina, Katherine V. Houser, Galina V. Yamshchikov, et al.. (2019). Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial. PLoS ONE. 14(9). e0222178–e0222178.
7.
Madaline, Theresa, Ruth Eisenberg, Wenzhu Mowrey, et al.. (2019). Early Infectious Disease Consultation Is Associated With Lower Mortality in Patients With Severe Sepsis or Septic Shock Who Complete the 3-Hour Sepsis Treatment Bundle. Open Forum Infectious Diseases. 6(10).
8.
Houser, Katherine V., Galina V. Yamshchikov, Abbie R. Bellamy, et al.. (2018). DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial. PLoS ONE. 13(11). e0206837–e0206837.
9.
Chung, Philip, et al.. (2017). Rapidly growing Mycobacterium infections after cosmetic surgery in medical tourists: the Bronx experience and a review of the literature. International Journal of Infectious Diseases. 63. 1–6.
10.
Coates, Emily E., Pamela Costner, Martha Nason, et al.. (2017). Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses. Clinical Nuclear Medicine. 42(5). 329–334.
11.
Sarwar, Uzma, et al.. (2016). Frequency of allergic contact dermatitis in hand eczema patients with European standard and corticosteroid series. Journal of Pakistan Association of Dermatology. 23(3). 289–294.
12.
Ledgerwood, Julie E., Zonghui Hu, Pamela Costner, et al.. (2015). Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemporary Clinical Trials. 44. 112–118.
13.
Ledgerwood, Julie E., Abbie R. Bellamy, Robert B. Belshe, et al.. (2015). DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial. PLoS ONE. 10(5). e0125914–e0125914.
14.
Sarwar, Uzma, Laura Novik, Mary E. Enama, et al.. (2014). Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial. PLoS ONE. 9(9). e106240–e106240.
15.
Chang, Lee-Jah, Kimberly A. Dowd, Floreliz Mendoza, et al.. (2014). Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. The Lancet. 384(9959). 2046–2052.
16.
Coates, Emily E., Pamela Costner, Troy J. Kemp, et al.. (2014). Comparison of adaptive and innate immune responses induced by licensed vaccines for human papillomavirus. Human Vaccines & Immunotherapeutics. 10(12). 3446–3454.
17.
Sarwar, Uzma, et al.. (2010). Frequency of Allergic Contact Dermatitis in Patients with Chronic Eczema. Annals of King Edward Medical University. 16.
18.
Sarwar, Uzma, Sandra Sitar, & Julie E. Ledgerwood. (2010). Filovirus emergence and vaccine development: A perspective for health care practitioners in travel medicine. Travel Medicine and Infectious Disease. 9(3). 126–134.
19.
Christensen, Gitte Lund, Christian D. Kelstrup, Uzma Sarwar, et al.. (2010). Quantitative Phosphoproteomics Dissection of Seven-transmembrane Receptor Signaling Using Full and Biased Agonists. Molecular & Cellular Proteomics. 9(7). 1540–1553.
20.
Aaronson, Philip I., et al.. (2006). A role for voltage‐gated, but not Ca2+‐activated, K+channels in regulating spontaneous contractile activity in myometrium from virgin and pregnant rats. British Journal of Pharmacology. 147(7). 815–824.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Claudia R. Libertin Breakdown of academic impact, for papers by Michael T. Melia Breakdown of academic impact, for papers by Francisco Moreno Breakdown of academic impact, for papers by Joshua A. Lieberman Breakdown of academic impact, for papers by Craig S. Boutlis Breakdown of academic impact, for papers by Robert Luo Breakdown of academic impact, for papers by Isabelle Ravaux Breakdown of academic impact, for papers by Alice Pong Breakdown of academic impact, for papers by Xiaohui Wang Breakdown of academic impact, for papers by Bruno Granwehr